Is a complete TPEX/6661 research report available?

No complete published report is available for tpex/6661 (TPEX/6661) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

tpex/6661 stock profile: metrics, valuation and analysis

Market cap	379.9M
Revenue (ttm)	398.9M
Net income (ttm)	-1.6M
EPS (ttm)	-NT$0.07
Shares out	23.3M
Volume	2,000
Beta	0.20

All TPEX/6661 indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

TWD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 464.2M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Diagnostics & Research
Isin	TW0006661002
Last refreshed	2026-09-08
Market cap	TWD 379.9M
Price	TWD 16.3
Price currency	TWD
Sector	Healthcare
Sector PE	88.9
Sector PE Fwd	27.78
Sic	8734
Symbol	tpex/6661
Website	https://www.welgene.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.43%
EV/EBITDA	16.32x
EV/Sales	1.16x
FCF yield	-26.96%
P/B ratio	1.37x
P/S ratio	0.95x
PE Ratio10 Y	84.55x
PE Ratio5 Y	158.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-0.62%
EBITDA Margin	3.59%
Gross margin	41.83%
Gross Profit	TWD 166.9M
Gross Profit Growth	13.66%
Gross Profit Growth Q	13.82%
Gross Profit Growth3 Y	11.62%
Gross Profit Growth5 Y	3.33%
Net Income	TWD -1.6M
Net Income Growth Years	2%
Pretax Margin	-0.37%
Profit Margin	-0.41%
Profitable Years	2
ROA	-0.26
Roa5y	0.83
ROCE	-0.5
ROE	-0.49
Roe5y	1.52
ROIC	-0.76
Roic5y	3.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-19.91%
Cagr3y	-11.35%
Cagr5y	-8.34%
Div CAGR3	-48.66%
EPS Growth Years	2
OCF Growth	-55.11%
OCF Growth10 Y	6.29%
OCF Growth3 Y	-18.67%
OCF Growth5 Y	27.26%
Revenue Growth	15.25x
Revenue Growth Q	18.98x
Revenue Growth Qo Q	27.99x
Revenue Growth Quarters	8x
Revenue Growth Years	2x
Revenue Growth3 Y	13.76x
Revenue Growth5 Y	3.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.67
Assets	TWD 658.6M
Cash	TWD 201.3M
Current Assets	TWD 306.9M
Current Liabilities	TWD 160.5M
Debt	TWD 281.2M
Debt EBITDA	TWD 9.89
Debt Equity	TWD 1.01
Debt FCF	TWD -2.75
Equity	TWD 277.6M
Interest Coverage	-0.53
Liabilities	TWD 381M
Long Term Assets	TWD 351.7M
Long Term Liabilities	TWD 220.5M
Net Cash	TWD -79.9M
Net Cash By Market Cap	TWD -21.03
Net Debt EBITDA	TWD 5.58
Net Debt Equity	TWD 0.29
Tangible Book Value	TWD 256.9M
Tangible Book Value Per Share	TWD 11.02
WACC	3.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.91
Inventory Turnover	4.69
Net Working Capital	TWD 6.1M
Quick ratio	1.51
Working Capital	TWD 146.4M
Working Capital Turnover	TWD 2.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	TWD 0
Last Dividend	TWD 0.18

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-19.9%
200-day SMA	18.19
3Y total return	-30.34%
50-day SMA	17.33
50-day SMA vs 200-day SMA	50under200
5Y total return	-35.3%
All Time High	41.5
All Time High Change	-60.72%
All Time High Date	2020-09-15
All Time Low	15
All Time Low Change	8.67%
All Time Low Date	2018-10-11
ATR	0.58
Beta	0.2
Beta1y	-0
Beta2y	0.23
Ch YTD	-12.37
High	16.3
High52	24.05
High52 Date	2025-09-11
High52ch	-32.22%
Low	16.3
Low52	15.5
Low52 Date	2026-06-11
Low52ch	5.16%
Ma50ch	-5.95%
Price vs 200-day SMA	-10.37%
RSI	41.97
RSI Monthly	33.99
RSI Weekly	40.17
Sharpe ratio	-0.65x
Sharpe Ratio3y	-0.16x
Sharpe Ratio5y	-0.2x
Sortino ratio	-0.76
Sortino Ratio3y	-0.09
Sortino Ratio5y	-0.13
Tr YTD	-12.37
Tr1m	-8.68%
Tr1w	-4.68%
Tr3m	-0.31%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,889,701%
Net Borrowing	85,461,000
Shares Insiders	10.49%
Shares Out	23,304,248
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	6,111.75x
Bv Per Share	11.72
CAPEX	TWD -131.5M
Ch1m	-8.68
Ch1w	-4.68
Ch1y	-19.9
Ch3m	-0.31
Ch3y	-30.34
Ch5y	-37.31
Ch6m	-13.53
Change	0%
Change From Open	0
Close	16.3
Days Gap	0
Depreciation Amortization	16,799,000
Dollar Volume	32,600
Earnings Date	2026-11-10
EBIT	TWD -2.5M
EBITDA	TWD 14.3M
EPS	TWD -0.07
F Score	3
FCF	TWD -102.4M
FCF EV Yield	-22.06x
FCF Per Share	TWD -4.39
Financing CF	85,348,000
Fiscal Year End	December
Founded	2,003
Income Tax	TWD -107,000
Investing CF	-127,350,000
Is Primary Listing	1
Last Earnings Date	2025-11-07
Last Report Date	2026-06-30
Last Split Date	2018-08-17
Last Split Type	Forward
Ma150	17.96
Ma150ch	-9.23%
Ma20	17.01
Ma20ch	-4.19%
Net CF	-12,909,000
Next Earnings Date	2026-11-10
Open	16.3
P OCF Ratio	13.06
Ppne	309,311,000
Price Date	2026-09-08
Price EBITDA	TWD 26.55
Ptbv Ratio	1.48
Relative Volume	0.33x
Revenue	398,915,000x
Tax By Revenue	-0.03x
Tr6m	-13.53%
Volume	2,000
Z Score	1.59

TPEX/6661 (TPEX/6661)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6661

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6661 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6661

Frequently asked questions